Business · 24/09/2025Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 72 Abbreviated New Drug Applications
Summary
The US Food and Drug Administration (FDA) has withdrawn the approval of 72 abbreviated new drug applications (ANDAs) from multiple applicants, following notification that the corresponding drug products were no longer marketed.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →